Pancreatic Cancer Research

ResearcherColumbia UniversityActive in the last 2 years

Ruth Aroon White

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4274-4468; OpenAlex author ID A5103083193. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 5

  1. Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma. First author DOI 10.1093/oncolo/oyag091↗
  2. Impact of β-Blockers, Statins, and Cholinergic Agents on Clinical Outcomes in Pancreatic Cancer: A Retrospective VA Cohort Study. Co-author DOI 10.1158/1055-9965.epi-26-0062↗
  3. A phase 0, window of opportunity study of parasympathetic stimulation with bethanechol in localized pancreatic adenocarcinoma prior to surgery. Co-author DOI 10.1093/oncolo/oyaf162↗
  4. Nerves on tr[ac]k to support pancreatic cancer metabolism. Co-author DOI 10.1038/s41422-020-00462-w↗
  5. Interleukin-1β-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression. Co-author DOI 10.1136/gutjnl-2019-319912↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Susan Elaine Bates · 3 shared papers, 2025–2026 · strength 0.82
  2. Timothy Cragin Wang · 3 shared papers, 2021–2025 · strength 0.61
  3. Gulam Abbas Manji · 2 shared papers, 2025–2026 · strength 0.49
  4. Paul E. Oberstein · 2 shared papers, 2025–2026 · strength 0.49
  5. Tamas A. Gonda · 2 shared papers, 2021–2026 · strength 0.37
  6. Keith Magnus Sigel · 1 shared paper, 2026 · strength 0.33
  7. Jason Cham · 1 shared paper, 2026 · strength 0.33
  8. Jiheum Park · 1 shared paper, 2026 · strength 0.33
  9. Tito Fojo · 1 shared paper, 2026 · strength 0.33
  10. Naomi Yamamoto · 1 shared paper, 2026 · strength 0.26
  11. Jacob K.R. Jamison · 1 shared paper, 2026 · strength 0.26
  12. Sita Kugel · 1 shared paper, 2026 · strength 0.26
  13. Rachael Ann Safyan · 1 shared paper, 2026 · strength 0.26
  14. Kazuki N. Sugahara · 1 shared paper, 2025 · strength 0.22
  15. Michael D. Kluger · 1 shared paper, 2025 · strength 0.22
  16. Beth Schrope · 1 shared paper, 2025 · strength 0.22
  17. John A. Chabot · 1 shared paper, 2025 · strength 0.22
  18. Alina Cornelia Iuga · 1 shared paper, 2021 · strength 0.11
  19. Takayuki Tanaka · 1 shared paper, 2021 · strength 0.11
  20. Marina Macchini · 1 shared paper, 2021 · strength 0.11
  21. Ryota Takahashi · 1 shared paper, 2021 · strength 0.11
  22. Bernhard Willibald Renz · 1 shared paper, 2021 · strength 0.11
  23. Masaki Sunagawa · 1 shared paper, 2021 · strength 0.11
  24. Kenneth P. Olive · 1 shared paper, 2021 · strength 0.11
  25. Christoph Benedikt Westphalen · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.